Skip to main content
Top

Current Cardiology Reports

Issue 11/2022

Content (21 Articles)

Role of Cardiac MRI Imaging of Focal and Diffuse Inflammation and Fibrosis in Cardiomyopathy Patients Who Have Pacemakers/ICD Devices

  • Cardiomyopathy
  • Myocardial Disease (A Abbate and M Merlo, Section Editors)

Ananna Zaman, Samantha Zhao, Jordana Kron, Antonio Abbate, Anna Tomdio, W. Gregory Hundley, Jennifer H. Jordan

Genetic Testing as a Guide for Treatment in Dilated Cardiomyopathies

Soledad García-Hernandez, Lorenzo Monserrat Iglesias

Artificial Intelligence Applied to Cardiomyopathies: Is It Time for Clinical Application?

  • Cardiomyopathy
  • Myocardial Disease (A Abbate and M Merlo, Section Editors)

Kyung-Hee Kim, Joon-Myung Kwon, Tara Pereira, Zachi I. Attia, Naveen L. Pereira

Genotype–phenotype Correlates in Arrhythmogenic Cardiomyopathies

  • Cardiomyopathy
  • Myocardial Disease (A Abbate and M Merlo, Section Editors)

Brittney Murray, Cynthia A. James

Beyond Sarcomeric Hypertrophic Cardiomyopathy: How to Diagnose and Manage Phenocopies

  • Cardiomyopathy
  • Myocardial Disease (A Abbate and M Merlo, Section Editors)

Maurizio Pieroni, Michele Ciabatti, Elisa Saletti, Valentina Tavanti, Pasquale Santangeli, Lucia Martinese, Francesco Liistro, Iacopo Olivotto, Leonardo Bolognese

Echocardiographic Differentiation of Pericardial Constriction and Left Ventricular Restriction

Hardeep Kaur Grewal, Manish Bansal

Three-Dimensional Echocardiography for Tricuspid Valve Assessment

Claudia Escabia, Antoni Bayes-Genis, Victoria Delgado

Pericardiectomy and Pericardial Window for the Treatment of Pericardial Disease in the Contemporary Era

  • Pericardiectomy
  • Pericardial Disease (AL Klein and CL Jellis, Section Editors)

Nicholas A. Oh, Carolyn Hennecken, Jef Van den Eynde, Ilias P. Doulamis, Dimitrios V. Avgerinos, Polydoros N. Kampaktsis

Autoimmune Pericarditis: Multimodality Imaging

Ghazaleh Goldar, Cassandra Garraud, Aaron A. Sifuentes, Heba Wassif, Vardhmaan Jain, Allan L. Klein

Integrating Advanced Lipid Testing and Biomarkers in Assessment and Treatment

  • Biomarkers
  • Lipid Abnormalities and Cardiovascular Prevention (ED Michos, Section Editor)

Alexandra Vaio Sykes, Neeja Patel, Danielle Lee, Pam R. Taub

PCSK9 Inhibitor Wars: How Does Inclisiran Fit in with Current Monoclonal Antibody Inhibitor Therapy? Considerations for Patient Selection

  • Open Access
  • Dyslipidemia
  • Lipid Abnormalities and Cardiovascular Prevention (ED Michos, Section Editor)

Natalie Arnold, Wolfgang Koenig

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

  • Open Access
  • Coronary Heart Disease
  • Lipid Abnormalities and Cardiovascular Prevention (ED Michos, Section Editor)

Fistra Janrio Tandirerung

New Way to “SCORE” Risk: Updates on the ESC Scoring System and Incorporation into ESC Cardiovascular Prevention Guidelines

  • Lipid Abnormalities and Cardiovascular Prevention (ED Michos, Section Editor)

Ian M. Graham, Emanuele Di Angelantonio, Radu Huculeci, Ian M. Graham, Emanuele Di Angelantonio, Dirk De Bacquer, Brian Ference, Martin Halle, Radu Huculeci, John McEvoy, Adam Timmis, Panos Vardas, Frank Visseren

Cardio-oncology: Implications for Clinical Practice for Women

  • Breast Cancer
  • Women and Cardiovascular Health (N Goldberg and S Lewis, Section Editors)

Seyed Ebrahim Kassaian, Bhumika Gandhi, Ana Barac

Autonomic Testing Optimizes Therapy for Heart Failure and Related Cardiovascular Disorders

Nicholas L. DePace, Joe Colombo, Kaushik Mandal, Howard J. Eisen

Heart Failure in Complex Congenital Heart Disease of the Adult

Anisa Chaudhry, Julia Selwyn, Elizabeth Adams, Elisa A. Bradley

Emerging Therapeutic Targets for Heart Failure

Maneesha Sharma, Lokesh Kumar Bhatt

Acute Coronary Syndromes Among Patients with Prior Coronary Artery Bypass Surgery

Denada S. Palm, Awa Drame, David J. Moliterno, David Aguilar

Stroke Prevention in Atrial Fibrillation

  • Cerebral Ischemia
  • Global Cardiovascular Health (L Sperling and D Gaita, Section Editors)

Xu Gao, Rod Passman

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME